专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

21. 发明授权

US06859878B1 Universal userid and password management for internet connected devices 失效
标题翻译：互联网连接设备的通用用户名和密码管理
公开(公告)号：US06859878B1
公开(公告)日：2005-02-22
申请号：US09428566
申请日：1999-10-28
申请人： David Andrews Kerr , David Medina , Mark A. Peloquin , Raymond J. Venditti
发明人： David Andrews Kerr , David Medina , Mark A. Peloquin , Raymond J. Venditti
IPC分类号： G06F21/00 , H04L29/06 , H04L9/00
CPC分类号： H04L63/083 , G06F21/41 , H04L63/123
摘要： An improved system, method, and computer program product is provided to manage userid/password combinations by utilizing a universally accessible Internet location. This site stores and manages an encrypted database containing the customers multiple userid and password combinations, and also acts as the repository and distribution center for the software used to access and manage the database by the customer. In one embodiment, these applications are designed to work seamlessly with the Internet connection-software (e.g. a set of buttons on a browsers tool bar). Encryption is used on both the client and/or server side to ensure security and integrity.
摘要翻译：提供改进的系统，方法和计算机程序产品，以通过利用普遍可访问的因特网位置来管理用户名/密码组合。该网站存储和管理包含客户多个用户名和密码组合的加密数据库，并且还充当用于由客户访问和管理数据库的软件的存储库和分发中心。在一个实施例中，这些应用被设计为与因特网连接软件（例如浏览器工具栏上的一组按钮）无缝地工作。在客户端和/或服务器端都使用加密来确保安全性和完整性。

22. 发明授权

US06448293B1 Diphenyl ether compounds useful in therapy 失效
标题翻译：用于治疗的二苯醚化合物
公开(公告)号：US06448293B1
公开(公告)日：2002-09-10
申请号：US09810378
申请日：2001-03-16
申请人： Mark David Andrews , David Hepworth , Donald Stuart Middleton , Alan Stobie
发明人： Mark David Andrews , David Hepworth , Donald Stuart Middleton , Alan Stobie
IPC分类号： C07C21758
CPC分类号： C07D231/38 , C07C45/71 , C07C47/55 , C07C47/575 , C07C205/44 , C07C217/58 , C07C229/38 , C07C237/28 , C07C255/43 , C07C255/59 , C07C311/05 , C07C311/08 , C07C311/37 , C07C317/32 , C07C323/20 , C07C323/32 , C07C323/67 , C07C2601/02 , C07C2601/08 , C07D231/12 , C07D233/56 , C07D249/06 , C07D249/08 , C07D295/096 , C07D295/192
摘要： A compound of general formula (I), or pharmaceutically acceptable salts, solvates or polymorphs thereof; wherein; R1 and R2, which may be the same or different, are hydrogen, C1-C6alkyl, (CH2)m (C3-C6cycloalkyl) wherein m =0, 1, 2 or 3, or R1 and R2 together with the nitrogen to which they are attached form an azetidine ring; each R3 is independently CF3, OCF3, C1-4alkylthio or C1-C4alkoxy; n is 1, 2 or 3; and R4 and R5, which may be the same or different, are: A—X, wherein A =—CH=CH— or —(CH2)p— where p is 0, 1 or 2; X is hydrogen, F, Cl, Br, I, CONR6R7, SO2NR6R7, SO2NHC(=O)R6, OH, C1-4alkoxy, NR8SO2R9, NO2, NR6R11, CN, CO2R10, CHO, SR10, S(O)R9 or SO2R10; R6, R7, R8 and R10 which may be the same or different, are hydrogen or C1-6alkyl optionally substituted independently by one or more R12; R9 is C1-6 alkyl optionally substituted independently by one or more R12; R11 is hydrogen, C1-6 alkyl optionally substituted independently by one or more R12, C(O)R6, CO2R9, C(O)NHR6 or SO2NR6R7; R12 is F, OH, CO2H, C3-6cycloalkyl, NH2, CONH2, C1-6alkoxy, C1-6alkoxycarbonyl or a 5- or 6-membered heterocyclic ring containing 1, 2 or 3 heteroatoms selected from N, S and O optionally substituted independently by one or more R13; or R6 and R7, together with the nitrogen to which they are attached, form a 4-, 5- or 6-membered heterocyclic ring optionally substituted independently by one or more R13; or a 5- or 6-membered heterocyclic ring containing 1, 2 or 3 heteroatoms selected from N, S and O, optionally substituted independently by one or more R13; wherein R13 is hydroxy, C1-C4alkoxy, F, C1-C6alkyl, haloalkyl, haloalkoxy, —NH2, —NH(C1-C6alkyl) or —N(C1-C6alkyl)2; wherein when R1 and R2 are methyl, R4 and R5 are hydrogen and n is 1, R3is not a —SMe group para to the ether linkage linking rings A and B.
摘要翻译：通式（I）的化合物或其药学上可接受的盐，溶剂化物或多晶型物; 其中; R 1和R 2可以相同或不同，为氢，C 1 -C 6烷基，（CH 2）m（C 3 -C 6环烷基），其中m = 0,1,2或3，或R 1和R 2与它们连接形成氮杂环丁烷环; 每个R 3独立地为CF 3，OCF 3，C 1-4烷硫基或C 1 -C 4烷氧基; n为1,2或3; 并且R 4和R 5可以相同或不同，为：A-X，其中A = -CH = CH-或 - （CH 2）p - ，其中p为0,1或2; X是氢，F，Cl，Br，I，CONR6R7，SO2NR6R7，SO2NHC（= O）R6，OH，C1-4烷氧基，NR8SO2R9，NO2，NR6R11，CN，CO2R10，CHO，SR10，S（O）R9或SO2R10 ; R 6，R 7，R 8和R 10可以相同或不同，是氢或被一个或多个R 12独立地取代的C 1-6烷基; R9是任选被一个或多个R 12独立地取代的C 1-6烷基; R 11是氢，任选地被一个或多个R 12，C（O）R 6，CO 2 R 9，C（O）NHR 6或SO 2 NR 6 R 7取代的C 1-6烷基; R 12是F，OH，CO 2 H，C 3-6环烷基，NH 2，CONH 2，C 1-6烷氧基，C

23. 发明授权

US5919819A Dihydropyran derivatives as viral neuraminidase inhibitors 有权
标题翻译：二氢吡喃衍生物作为病毒神经氨酸酶抑制剂
公开(公告)号：US5919819A
公开(公告)日：1999-07-06
申请号：US000149
申请日：1998-09-14
申请人： David Andrews , Paul Jones , David Humber
发明人： David Andrews , Paul Jones , David Humber
IPC分类号： A61K31/00 , A61K31/35 , A61K31/351 , A61P31/00 , C07D309/28 , C07D315/00
CPC分类号： C07D309/28
摘要： Compounds of formula (I), wherein R.sup.1 represents NR.sup.5 R.sup.6, wherein R.sup.5 represents H or a hydrocarbon group optionally substituted by one or more of Br, Cl, F, I, CF.sub.3, NR.sup.7 R.sup.8, CO.sub.2 R.sup.9, CONR.sup.7 R.sup.8, COR.sup.9, OR.sup.10 or SR.sup.10, or a heteroaromatic group; and R.sup.6 represents a hydrocarbon group optionally substituted by one or more of Br, Cl, F, I, CF.sub.3, NR.sup.7 R.sup.8, CO.sub.2 R.sup.9, CONR.sup.7 R.sup.8, COR.sup.9, OR.sup.10 or SR.sup.10, or a heteroaromatic group; R.sup.2 represents a group SO.sub.2 R.sup.9 or COR.sup.9 ; R.sup.3 represents H, C.sub.1-6 -alkyl or C(=NR.sup.11)NR.sup.12 R.sup.13 ; R.sup.4 represents H or C.sub.1-6 alkyl; R.sup.7 and R.sup.8 each independently represent H, C.sub.1-6 alkyl or COR.sup.9 ; R.sup.9 represents C.sub.1-6 alkyl optionally substituted by one or more halogen atoms; R.sup.10 represents H, C.sub.1-6 -alkyl or phenyl; R.sup.11, R.sup.12 and R.sup.13 each independently represent H, C.sub.1-6 alkyl, amino, hydroxy, cyano or nitro; and X represents O or S; and their pharmaceutically acceptable derivatives are neuraminidase inhibitors useful in the treatment of viral infections.
摘要翻译： PCT No.PCT / AU96 / 00495 Sec。 371日期：1998年9月14日 102（e）1998年9月14日PCT PCT 1996年8月7日PCT公布。公开号WO97 / 06157 日期：1997年2月20日，式（I）的化合物，其中R 1表示NR 5 R 6，其中R 5表示H或任选被Br，Cl，F，I，CF 3，NR 7 R 8，CO 2 R 9，CONR 7 R 8，COR 9， OR10或SR10，或杂芳族基团; 并且R 6表示任选被Br，Cl，F，I，CF 3，NR 7 R 8，CO 2 R 9，CONR 7 R 8，COR 9，OR 10或SR 10中的一个或多个取代的烃基或杂芳基; R2代表基团SO2R9或COR9; R 3表示H，C 1-6 - 烷基或C（= NR 11）NR 12 R 13; R4表示H或C1-6烷基; R 7和R 8各自独立地表示H，C 1-6烷基或COR 9; R9表示任选被一个或多个卤素原子取代的C 1-6烷基; R 10表示H，C 1-6 - 烷基或苯基; R 11，R 12和R 13各自独立地表示H，C 1-6烷基，氨基，羟基，氰基或硝基; X表示O或S; 其药学上可接受的衍生物是可用于治疗病毒感染的神经氨酸酶抑制剂。

24. 外观设计

USD405098S Link 失效
公开(公告)号：USD405098S
公开(公告)日：1999-02-02
申请号：US80968
申请日：1997-10-17
申请人： Charles David Andrews , Gordon Edward Miller , Larry A. Sliker , Donald Rodney Flatau
设计人： Charles David Andrews , Gordon Edward Miller , Larry A. Sliker , Donald Rodney Flatau

25. 发明授权

US08587422B2 Occupant sensing system 有权
标题翻译：乘员感应系统
公开(公告)号：US08587422B2
公开(公告)日：2013-11-19
申请号：US13074830
申请日：2011-03-29
申请人： David Andrews , Jason Lisseman , Jerome Bosch
发明人： David Andrews , Jason Lisseman , Jerome Bosch
IPC分类号： B60Q1/00
CPC分类号： B60R21/01516 , B60N2/002 , B60R21/0152
摘要： An occupant sensing system for a vehicle includes a pressure sensitive material installed in one or more pressure sensing zones in or around at least one vehicle seat. The pressure sensitive material of each zone is configured to provide an electrical signal to a controller when pressure is applied. The controller determines at least one of occupant presence, position, and classification based on the electrical signal. The pressure sensitive material has at least one of a variable resistance and a variable capacitance based on the amount or type of pressure that is applied to the material. The at least one of a variable resistance and a variable capacitance changes characteristics of the electrical signal.
摘要翻译：用于车辆的乘员感测系统包括安装在至少一个车辆座椅内或周围的一个或多个压力感测区域中的压敏材料。每个区域的压敏材料构造成当施加压力时向控制器提供电信号。控制器基于电信号确定乘员存在，位置和分类中的至少一个。基于施加到材料的压力的量或类型，压敏材料具有可变电阻和可变电容中的至少一种。可变电阻和可变电容中的至少一个改变电信号的特性。

26. 发明申请

US20120258950A1 PYRROLO[2,3-d]PYRIMIDINE TROPOMYSIN-RELATED KINASE INHIBITORS 有权
标题翻译：吡咯并[2,3-d]吡咯烷TROPOMYSIN相关激酶抑制剂
公开(公告)号：US20120258950A1
公开(公告)日：2012-10-11
申请号：US13439131
申请日：2012-04-04
申请人： Mark David Andrews , Sharanjeet Kaur Bagal , Karl Richard Gibson , Kiyoyuki Omoto , Thomas Ryckmans , Sarah Elizabeth Skerratt , Paul Anthony Stupple
发明人： Mark David Andrews , Sharanjeet Kaur Bagal , Karl Richard Gibson , Kiyoyuki Omoto , Thomas Ryckmans , Sarah Elizabeth Skerratt , Paul Anthony Stupple
IPC分类号： A61K31/519 , A61P25/00 , A61K31/52 , C07D487/04 , C07D473/00
CPC分类号： C07D487/04 , A61K31/519 , C07D513/04
摘要： The present invention relates to compounds of Formula (I) and their pharmaceutically acceptable salts, wherein the substituents are as described herein, and their use in medicine, in particular as Trk antagonists.
摘要翻译：本发明涉及式（I）化合物及其药学上可接受的盐，其中取代基如本文所述，及其在药物中的用途，特别是作为Trk拮抗剂。

27. 发明授权

US08250448B1 Method of and apparatus for implementing a decoder 有权
标题翻译：用于实现解码器的方法和装置
公开(公告)号：US08250448B1
公开(公告)日：2012-08-21
申请号：US12056193
申请日：2008-03-26
申请人： David Andrews
发明人： David Andrews
IPC分类号： H03M13/03
CPC分类号： H03M13/2957 , H03M13/2993 , H03M13/3972 , H03M13/6502 , H03M13/6525
摘要： Method and apparatus for concatenated and interleaved turbo product code decoding are described. The turbo encoder include a plurality of decoders coupled to receive first portion of data, a processor coupled to receive second portion of the data, and a controller providing a plurality of control signals coupled to the plurality of decoders and the processor. A control signal of the plurality of control signals coupled to the processor when enabled configures the processor to pre-calculate the second portion of the data, where the second portion of the data is trellis termination data.
摘要翻译：描述了用于级联和交织的涡轮乘积码解码的方法和装置。所述turbo编码器包括耦合以接收数据的第一部分的多个解码器，耦合以接收所述数据的第二部分的处理器，以及提供耦合到所述多个解码器和所述处理器的多个控制信号的控制器。当启动时，耦合到处理器的多个控制信号的控制信号使处理器预先计算数据的第二部分，其中数据的第二部分是格状终止数据。

28. 发明申请

US20110167682A1 HEAVY DUTY EXCAVATOR BUCKET 审中-公开
标题翻译：重型挖掘机BUCKET
公开(公告)号：US20110167682A1
公开(公告)日：2011-07-14
申请号：US13039959
申请日：2011-03-03
申请人： Bruce Alexander Leslie , Bevan Hall , Simon Peter Orton , Derek Mulder , David Andrews
发明人： Bruce Alexander Leslie , Bevan Hall , Simon Peter Orton , Derek Mulder , David Andrews
IPC分类号： E02F3/50
CPC分类号： E02F3/40 , E02F3/60
摘要： A heavy duty excavator bucket is constructed with an exoskeletal structure comprising coupled cast components including a lip member, opposed wing members, junction members locatable between floor and side walls and side and rear walls and a cap rail structure extending between opposed wing members about the upper periphery of the bucket to form an integral structure. Steel plate floor, side wall and rear wall members extend between adjacent exoskeletal regions. The bucket may include a cast arch member extending between opposed wing members and a cast reinforcing member extending between opposed junction members adjacent said rear wall.
摘要翻译：重型挖掘机铲斗由外骨骼结构构成，该外骨骼结构包括耦合的铸件，包括唇形构件，相对的翼构件，可定位在地板和侧壁之间的接合构件以及侧壁和后壁以及围绕上部的相对翼构件之间延伸的盖轨道结构桶的周边形成一体的结构。钢板地板，侧壁和后壁构件在相邻的外骨骼区域之间延伸。铲斗可以包括在相对的翼构件之间延伸的铸造拱形构件和在邻近所述后壁的相对的连接构件之间延伸的铸造加强构件。

29. 发明申请

US20090054409A1 IMIDAZO [1,2-A] PYRIDINE HAVING ANTI-CELL-PROLIFERATION ACTIVITY 失效
标题翻译：具有抗细胞增殖活性的咪唑并[1,2-A]吡啶
公开(公告)号：US20090054409A1
公开(公告)日：2009-02-26
申请号：US12088678
申请日：2006-09-29
申请人： David Andrews , Andrew John Barker , Maurice Raymond Finlay , Clive Green , Clifford Jones
发明人： David Andrews , Andrew John Barker , Maurice Raymond Finlay , Clive Green , Clifford Jones
IPC分类号： A61K31/551 , C07D403/04 , C07D413/08 , C07D243/08 , A61K31/506 , A61P35/02 , A61P37/00 , A61P17/06 , A61P19/00 , A61P9/00 , A61P35/04 , A61K31/5377 , C07D239/02 , A61K31/496
CPC分类号： C07D471/04
摘要： Compounds of formula (I): which possess cell-cycle inhibitory activity are described.
摘要翻译：描述了具有细胞周期抑制活性的式（I）化合物。

30. 发明申请

US20090036459A1 Melanocortin Type 4 Receptor Agonist Piperidinoylpyrrolidines 有权
标题翻译：黑皮质素4型受体激动剂哌啶子基吡咯烷酮
公开(公告)号：US20090036459A1
公开(公告)日：2009-02-05
申请号：US12280444
申请日：2007-02-19
申请人： Mark David Andrews , Alan Daniel Brown , Mark Ian Lansdell , Nicholas William Summerhill
发明人： Mark David Andrews , Alan Daniel Brown , Mark Ian Lansdell , Nicholas William Summerhill
IPC分类号： A61K31/501 , C07D401/14 , A61P3/00 , A61K31/4545
CPC分类号： C07D401/14
摘要： The present invention relates to a class of melanocortin MCR4 agonists of general formula (I) wherein the variables and substituents are as defined herein and especially to selective MCR4 agonist compounds, to their use in medicine, particularly in the treatment of sexual dysfunction and obesity, to intermediates useful in their synthesis and to compositions containing them.
摘要翻译：本发明涉及一类通式（I）的黑皮质素MCR4激动剂，其中变量和取代基如本文所定义，特别是选择性MCR4激动剂化合物在医学中的用途，特别是用于治疗性功能障碍和肥胖症，可用于其合成的中间体和含有它们的组合物。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式